Mechanism of oral tolerance induction to therapeutic proteins
about
Targeted approaches to induce immune tolerance for Pompe disease therapyOral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel diseasePlant-made oral vaccines against human infectious diseases-Are we there yet?Plastid genomics in horticultural species: importance and applications for plant population genetics, evolution, and biotechnologyOral Delivery of Protein Drugs Bioencapsulated in Plant CellsGene therapy for hemophiliaOral tolerance to cancer can be abrogated by T regulatory cell inhibitionVaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human DiseasesSuppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cellsPlant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cellsT cells in the control of organ-specific autoimmunityOral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 DiabetesOral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells.Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.In vivo induction of regulatory T cells for immune tolerance in hemophilia.Edible plants for oral delivery of biopharmaceuticals.Innovating immune tolerance induction for haemophilia.Complexity of immune responses to AAV transgene products - Example of factor IX.An overview on the role of silica-based materials in vaccine development.Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce.Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice.Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.Gene Therapy With Regulatory T Cells: A Beneficial Alliance.Preexisting antigen-specific immune responses are modulated by oral KLH feeding in humans.Histological and immunological characteristics of the junctional epithelium.
P2860
Q26767363-868F71C8-F632-4988-9832-03A6078BBD19Q26768500-77FFD07D-44B5-4CAA-9844-04C90498ECA6Q26783111-F90F6022-F19D-4F0B-AF31-6C511C140277Q26797305-04717F47-DE26-4128-9CC8-3D1A576DDDE5Q28079063-1BD32249-64FE-43B2-99FA-D077589D37BCQ28081911-BBDAA198-433C-484F-BBD8-8AC3A2F991F6Q33618271-E23633BC-BA66-489A-8FC6-CD160769BDF8Q33870122-74D053F1-F27C-4F02-852C-AC5884BD9D71Q34137024-DEA48EC9-D113-486B-AA28-50418FEBD891Q35348677-52EF9543-4292-48BD-935F-CD9DAC57E32BQ35836118-90E1AD0D-FC5C-4D21-94A6-3796AC09B613Q35897441-3931D68E-370D-4CFF-91F9-90BF80747072Q36083396-68C2FFDD-8A87-4DA3-9054-73FEA326973EQ36252781-2CDA2DDF-2D88-4D36-91CC-C69D42142821Q36582796-97FBA8FF-2F59-4246-B731-C18FAA2687D4Q37541716-6CD605EF-CDB3-4627-884A-D3FED21D3039Q37620814-19C54FA3-0C74-4DBC-A771-7353FB9E3C45Q37638227-F304C0FF-70C0-4450-8C58-298058D26F29Q37836218-A104FA62-53E4-40ED-9E35-546B3C170ED8Q38574966-53CB8C6E-43FB-4BEC-B5DB-47C1A42BF6ACQ38796221-4D276371-C62F-448D-A492-06F1E9522915Q38894155-EAB909D1-8D82-461A-87DA-33BE183EE18CQ39394803-42B3575D-791F-4EE8-A234-30F86F8D70A4Q39781727-842F9E6F-62F9-4B37-A3A1-F4088F4110E4Q45864205-5D830DEF-7ADC-4196-97FD-8B9B8E57F286Q45874015-278059BC-1497-4FF0-B44D-16CC248D38FBQ45875675-1D3AEDA2-7F6A-4637-85EB-3BA997081D3FQ52721830-0814F51C-5316-45E8-9407-047933A7DD5DQ52867911-3489F367-4103-45DE-81FF-8FC9487AE609Q55479756-4127D26C-F625-4145-8054-A70996E95E0D
P2860
Mechanism of oral tolerance induction to therapeutic proteins
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mechanism of oral tolerance induction to therapeutic proteins
@ast
Mechanism of oral tolerance induction to therapeutic proteins
@en
Mechanism of oral tolerance induction to therapeutic proteins
@nl
type
label
Mechanism of oral tolerance induction to therapeutic proteins
@ast
Mechanism of oral tolerance induction to therapeutic proteins
@en
Mechanism of oral tolerance induction to therapeutic proteins
@nl
prefLabel
Mechanism of oral tolerance induction to therapeutic proteins
@ast
Mechanism of oral tolerance induction to therapeutic proteins
@en
Mechanism of oral tolerance induction to therapeutic proteins
@nl
P2093
P2860
P3181
P1476
Mechanism of oral tolerance induction to therapeutic proteins
@en
P2093
Alexandra Sherman
Cox Terhorst
Gongxian Liao
Henry Daniell
Kam W. Leong
Roland W. Herzog
Xiaomei Wang
P2860
P304
P3181
P356
10.1016/J.ADDR.2012.10.013
P407
P577
2013-06-15T00:00:00Z